Akebia Therapeutics, Inc. 10-K filing
Filed 2026-02-26 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001517022-26-000020
- Form type
- 10-K
- CIK
- 0001517022
- Primary document
- https://www.sec.gov/Archives/edgar/data/1517022/000151702226000020/akba-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Akebia Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $236.2M | - | - |
| Cost Of Revenue | $39.5M | - | - |
| Operating Income | $23.5M | - | - |
| Net Income | $-5.3M | - | - |
| Eps Basic | -0.02 | - | - |
| Eps Diluted | -0.02 | - | - |
| Cash And Equivalents | $184.8M | - | - |
| Total Assets | $376.6M | - | - |
| Total Liabilities | $344.0M | - | - |
| Shareholders Equity | $32.6M | - | - |
| Operating Cash Flow | $68.0M | - | - |
| Capital Expenditures | $291,000 | - | - |